Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Not Your Ordinary Rash.

Williams GR, Nerenz RD.

Clin Chem. 2019 Jun;65(6):733-737. doi: 10.1373/clinchem.2018.291344. No abstract available.

PMID:
31138547
2.

5-Oxoproline concentrations in acute acetaminophen overdose.

Mullins ME, Jones MS, Nerenz RD, Schwarz ES, Dietzen DJ.

Clin Toxicol (Phila). 2019 May 3:1-3. doi: 10.1080/15563650.2019.1609684. [Epub ahead of print]

PMID:
31050299
3.

The Curious Case of an Isolated Positive Hepatitis B Surface Antigen Result.

Nerenz RD, Felty CC, Cervinski MA.

Clin Chem. 2019 Mar;65(3):499-500. doi: 10.1373/clinchem.2018.294157. No abstract available.

PMID:
30819794
4.

Improved Performance of Point-of-Care Human Chorionic Gonadotropin Pregnancy Device.

Farnsworth CW, Nerenz RD, Gronowski AM.

Clin Chem. 2018 Oct;64(10):1539-1541. doi: 10.1373/clinchem.2018.293076. Epub 2018 Aug 1. No abstract available.

5.

Assessment of biotin interference with qualitative point-of-care hCG test devices.

Williams GR, Cervinski MA, Nerenz RD.

Clin Biochem. 2018 Mar;53:168-170. doi: 10.1016/j.clinbiochem.2018.01.018. Epub 2018 Jan 31.

PMID:
29395091
6.

Ready to Settle.

Shajani-Yi Z, Brunelle AA, Nerenz RD.

Clin Chem. 2017 Sep;63(9):1546-1547. doi: 10.1373/clinchem.2017.273045. No abstract available.

7.

Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device.

Nerenz RD, Gronowski AM, Grenache DG.

West J Emerg Med. 2017 Feb;18(2):324-325. doi: 10.5811/westjem.2016.10.32675. Epub 2016 Dec 6. No abstract available.

8.

Our Genome's "Dark Matter" Is the Next Frontier in Molecular Diagnostics.

Nerenz RD, Lefferts J.

Clin Chem. 2017 Mar;63(3):792-793. doi: 10.1373/clinchem.2016.268607. No abstract available.

9.

Omics in Reproductive Medicine: Application of Novel Technologies to Improve the IVF Success Rate.

Nerenz RD.

Adv Clin Chem. 2016;76:55-95. doi: 10.1016/bs.acc.2016.05.001. Epub 2016 Jun 16. Review.

PMID:
27645816
10.

Characterizing urinary hCGβcf patterns during pregnancy.

Nerenz RD, Yarbrough ML, Stenman UH, Gronowski AM.

Clin Biochem. 2016 Jul;49(10-11):777-81. doi: 10.1016/j.clinbiochem.2016.04.006. Epub 2016 Apr 14.

PMID:
27087510
11.

What's Wrong with These Pleural Fluid Samples?

Kukkar V, Miller VA, Richardson MA, Nerenz RD.

Clin Chem. 2016 Feb;62(2):415. doi: 10.1373/clinchem.2015.244707. No abstract available.

12.

Estimating the hCGβcf in urine during pregnancy.

Nerenz RD, Butch AW, Woldemariam GA, Yarbrough ML, Grenache DG, Gronowski AM.

Clin Biochem. 2016 Feb;49(3):282-6. doi: 10.1016/j.clinbiochem.2015.10.020. Epub 2015 Nov 2.

PMID:
26541857
13.

Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.

Nerenz RD, Butch AW, Ashby L, Woldemariam GA, Gronowski AM.

Clin Biochem. 2015 Aug;48(12):815-7. doi: 10.1016/j.clinbiochem.2015.04.015. Epub 2015 Apr 25.

PMID:
25916816
14.

Analytical performance evaluation of the i-STAT Total β-human chorionic gonadotropin immunoassay.

Sowder AM, Yarbrough ML, Nerenz RD, Mitsios JV, Mortensen R, Gronowski AM, Grenache DG.

Clin Chim Acta. 2015 Jun 15;446:165-70. doi: 10.1016/j.cca.2015.04.025. Epub 2015 Apr 25.

PMID:
25916696
15.

Confirmation of hCG Point-of-Care Qualitative Device Limitations in the Emergency Department.

Nerenz RD, Gronowski AM.

J Emerg Med. 2015 May;48(5):609-10. doi: 10.1016/j.jemermed.2014.07.064. Epub 2015 Mar 18. No abstract available.

PMID:
25797934
16.

Assessing the risk of false negative point-of-care urinary human chorionic gonadotropin device results due to beta core fragment.

Gronowski AM, Nerenz RD.

Clin Biochem. 2015 Feb;48(3):97-8. doi: 10.1016/j.clinbiochem.2015.01.001. Epub 2015 Jan 8. No abstract available.

PMID:
25578769
17.

Qualitative point-of-care human chorionic gonadotropin testing: can we defuse this ticking time bomb?

Nerenz RD, Gronowski AM.

Clin Chem. 2015 Mar;61(3):483-6. doi: 10.1373/clinchem.2014.233627. Epub 2014 Dec 17. No abstract available.

18.

In reply.

Nerenz RD, Gronowski AM.

Clin Chem. 2014 Dec;60(12):1580-1. doi: 10.1373/clinchem.2014.231977. Epub 2014 Sep 23. No abstract available.

19.

Improved performance of point-of-care and over-the-counter qualitative human chorionic gonadotropin measurement devices.

Nerenz RD, Gronowski AM.

Clin Chem. 2014 Dec;60(12):1576-8. doi: 10.1373/clinchem.2014.229435. Epub 2014 Aug 26. No abstract available.

20.
21.

Premenopausal amenorrhea: what's in a number?

Nerenz RD, Jungheim ES, Lockwood CM.

Clin Chem. 2014 Jan;60(1):29-33; discussion 33-4. doi: 10.1373/clinchem.2013.202499. No abstract available.

22.

Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment.

Nerenz RD, Gronowski AM.

Clin Chem. 2013 Nov;59(11):1672-4. doi: 10.1373/clinchem.2013.212795. Epub 2013 Aug 28. No abstract available.

23.

Mouse Rankl expression is regulated in T cells by c-Fos through a cluster of distal regulatory enhancers designated the T cell control region.

Bishop KA, Coy HM, Nerenz RD, Meyer MB, Pike JW.

J Biol Chem. 2011 Jun 10;286(23):20880-91. doi: 10.1074/jbc.M111.231548. Epub 2011 Apr 12.

24.

Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3.

Pike JW, Meyer MB, Martowicz ML, Bishop KA, Lee SM, Nerenz RD, Goetsch PD.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):130-5. doi: 10.1016/j.jsbmb.2010.02.036. Epub 2010 Mar 7.

25.

Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.

Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW.

Mol Endocrinol. 2010 Jan;24(1):128-47. doi: 10.1210/me.2009-0140. Epub 2009 Nov 6.

26.

The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes.

Zella LA, Meyer MB, Nerenz RD, Pike JW.

Endocrinology. 2009 Aug;150(8):3448-56. doi: 10.1210/en.2009-0113. Epub 2009 May 7.

27.

An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3.

Nerenz RD, Martowicz ML, Pike JW.

Mol Endocrinol. 2008 May;22(5):1044-56. doi: 10.1210/me.2007-0380. Epub 2008 Jan 17.

28.

Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo.

Meyer MB, Zella LA, Nerenz RD, Pike JW.

J Biol Chem. 2007 Aug 3;282(31):22344-52. Epub 2007 Jun 7.

Supplemental Content

Loading ...
Support Center